These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6157306)

  • 1. Central serotonin deficiency--a factor which increases depression vulnerability?
    van Praag HM; de Haan S
    Acta Psychiatr Scand Suppl; 1980; 280():89-96. PubMed ID: 6157306
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    van Praag HM; Korf J
    J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
    [No Abstract]   [Full Text] [Related]  

  • 3. Central monoamine metabolism in depressions. I. Serotonin and related compounds.
    van Praag HM
    Compr Psychiatry; 1980; 21(1):30-43. PubMed ID: 6153593
    [No Abstract]   [Full Text] [Related]  

  • 4. Central monoamine deficiency in depressions: causative of secondary phenomenon?
    van Praag HM; Korf J
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Sep; 8(5):322-6. PubMed ID: 1085937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Central serotonin metabolism in depression].
    van Praag HM
    Ned Tijdschr Geneeskd; 1980 Jun; 124(24):964-71. PubMed ID: 6966766
    [No Abstract]   [Full Text] [Related]  

  • 6. The indoleamine hypothesis of depression: an overview and pilot study.
    Zarcone VP; Berger PA; Brodie KH; Sack R; Barchas JD
    Dis Nerv Syst; 1977 Aug; 38(8):646-53. PubMed ID: 328245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a biochemical classification of depression.
    van Praag HM
    Adv Biochem Psychopharmacol; 1974; 11(0):357-68. PubMed ID: 4845704
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine metabolism and depression in Parkinson patients.
    Puite JK; Schut T; van Praag HM; Lakke JP
    Psychiatr Neurol Neurochir; 1973; 76(1):61-70. PubMed ID: 4699106
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin metabolism in depression: clinical application of the probenecid test.
    van Praag HM; Korf J
    Int Pharmacopsychiatry; 1974; 9(1):35-51. PubMed ID: 4599325
    [No Abstract]   [Full Text] [Related]  

  • 10. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Byerley WF; Risch SC
    J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biogenic amine synthesis defect in dihydropteridine reductase deficiency.
    Koslow SH; Butler IJ
    Science; 1977 Nov; 198(4316):522-3. PubMed ID: 20665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical aspects of depression.
    Coppen AJ
    Int Psychiatry Clin; 1969; 6(2):53-81. PubMed ID: 5817856
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
    Misionzhnik EIu; Vertogradova OP; Krasnov VN; Salenko BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):543-51. PubMed ID: 6168150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.
    van Praag HM; Korf J; Puite J
    Nature; 1970 Mar; 225(5239):1259-60. PubMed ID: 5435360
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of l-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients.
    Takahashi S; Kondo H; Kato N
    J Psychiatr Res; 1975 Nov; 12(3):177-87. PubMed ID: 1081591
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotoninergic dysfunction in the 47, XYY syndrome.
    Bioulac B; Benezech M; Renaud B; Noel B; Roche D
    Biol Psychiatry; 1980 Dec; 15(6):917-23. PubMed ID: 6161648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.
    Ridges AP
    Postgrad Med J; 1976; 52(3 suppl):9-17. PubMed ID: 785425
    [No Abstract]   [Full Text] [Related]  

  • 18. A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients.
    van Praag HM; Korf J
    Biol Psychiatry; 1971; 3(2):105-12. PubMed ID: 5089909
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin and severe affective disorders.
    McLeod WR; McLeod MF
    Aust N Z J Psychiatry; 1971 Dec; 5(4):289-95. PubMed ID: 5292061
    [No Abstract]   [Full Text] [Related]  

  • 20. Depression vulnerability and 5-hydroxytryptophan prophylaxis.
    van Praag H; de Hann S
    Psychiatry Res; 1980 Sep; 3(1):75-83. PubMed ID: 6160599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.